Billions exit bank accounts after years of inflows

By Editor / October 1, 2021 / 0 Comments

Saab builds 9-3 test cars ahead of 2021 production launch

By Editor / October 19, 2021 / 0 Comments

Lithia relaxes grip on store operations

By Editor / October 9, 2021 / 0 Comments

Study raises new concern about earthquakes and fracking fluids

By Editor / September 27, 2021 / 0 Comments

Kirobo the talking robot blasts into space on historic mission

By Editor / November 6, 2021 / 0 Comments

Whooping cough vaccine protection wanes as kids age

Whooping cough vaccine protection wanes as kids age

Protection against whooping cough starts to weaken a few years after preschool children get their final shot, according to a U.S. study, meaning that some children may be at risk of developing the disease before they can get a booster shot.

The U.S. Centers for Disease Control and Prevention (CDC) recommends a booster shot at age 11 or 12. The usual practice is to give five doses of diphtheria, tetanus and pertussis (DTaP) shots, the last at age four to six.

“This evaluation reports steady increase in risk of pertussis in the years after completion of the 5-dose DTaP vaccines,” wrote lead author Sara Tartof in the study, which appeared in Pediatrics.

Tartof, who is from Southern California Permanente Medical Group in Pasadena, and her team used immunization records and state-wide whooping cough data to track more than 400,000 children in the states of Minnesota and Oregon. All were born between 1998 and 2003 and received the recommended series of five shots.

Over the following years, 458 children from Minnesota came down with whooping cough. The rate of new cases rose from 16 per 100,000 in the first year after their most recent shot, to 138 per 100,000 in year six. In Oregon, there were 89 cases – six per 100,000 in the first year and 24 per 100,000 in the sixth.

“What has become apparent is there’s a fairly dramatic and startling increase in pertussis in children in the seven- to 10-year-old age group,” said H Cody Meissner, a pediatrician from Tufts University School of Medicine who did not take part in the study.

Meissner and other researchers think that trend results from a change in the 1990s to a new type of pertussis vaccine, called an acellular vaccine, which comes with fewer side effects than the original whole-cell version.

But researchers also said that switching back to the whole-cell version, at least for the first couple of shots, could improve protection as children get older. But even though the side effects for that shot were mild, that is unlikely to happen.

(See More)